Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00152958
Status:
COMPLETED
Last Update Posted:
2013-11-19
First Post:
2005-09-08
Brief Title:
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding 6-month Treatment With Open-label Pramipexole Including Titration 0125 025 05 075 mg Orally qn
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
248546
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None